Disclosed are thienopyrimidinone derivatives as antagonists that act on metabotropic glutamate receptor subtype 1. The thienopyrimidinone derivatives show pharmacological activity against metabotropic glutamate receptor-related diseases, including pain, such as neuropathic pain and migraine, psychiatric diseases, such as anxiety disorder and schizophrenia, urinary incontinence, and neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease. Also disclosed are methods for preparing the thienopyrimidinone derivatives, and pharmaceutical compositions containing the thienopyrimidinone derivatives as active ingredients.
本发明涉及
噻唑嘧啶酮衍
生物,作为代谢型谷
氨酸受体亚型1的
拮抗剂。该
噻唑嘧啶酮衍
生物对代谢型谷
氨酸受体相关疾病具有药理活性,包括疼痛,如神经病性疼痛和偏头痛,精神疾病,如焦虑症和精神分裂症,尿失禁以及神经退行性疾病,如帕
金森病和阿尔茨海默病。本发明还涉及制备
噻唑嘧啶酮衍
生物的方法,以及含有该
噻唑嘧啶酮衍
生物作为活性成分的药物组合物。